Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
